Morgan Stanley’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.9M Buy
2,309,061
+999,011
+76% +$16M ﹤0.01% 2198
2025
Q1
$22.4M Buy
1,310,050
+299,426
+30% +$5.12M ﹤0.01% 2580
2024
Q4
$25M Buy
1,010,624
+192,882
+24% +$4.78M ﹤0.01% 2545
2024
Q3
$23.3M Buy
817,742
+704
+0.1% +$20.1K ﹤0.01% 2651
2024
Q2
$21.6M Sell
817,038
-120,923
-13% -$3.19M ﹤0.01% 2578
2024
Q1
$30.3M Sell
937,961
-125,045
-12% -$4.04M ﹤0.01% 2233
2023
Q4
$44.8M Buy
1,063,006
+724,123
+214% +$30.5M ﹤0.01% 2575
2023
Q3
$13M Sell
338,883
-198,173
-37% -$7.61M ﹤0.01% 2873
2023
Q2
$10.2M Buy
537,056
+309,965
+136% +$5.88M ﹤0.01% 3142
2023
Q1
$3.52M Buy
227,091
+56,841
+33% +$882K ﹤0.01% 4066
2022
Q4
$3.02M Buy
170,250
+77,819
+84% +$1.38M ﹤0.01% 4162
2022
Q3
$516K Sell
92,431
-67,240
-42% -$375K ﹤0.01% 5254
2022
Q2
$622K Sell
159,671
-68,351
-30% -$266K ﹤0.01% 5309
2022
Q1
$1.26M Sell
228,022
-268,888
-54% -$1.48M ﹤0.01% 4844
2021
Q4
$4.23M Sell
496,910
-368,336
-43% -$3.14M ﹤0.01% 3886
2021
Q3
$7.52M Sell
865,246
-677,126
-44% -$5.88M ﹤0.01% 3260
2021
Q2
$16.3M Buy
1,542,372
+789,721
+105% +$8.35M ﹤0.01% 2396
2021
Q1
$12.1M Buy
752,651
+675,882
+880% +$10.8M ﹤0.01% 2457
2020
Q4
$3.55M Buy
76,769
+71,395
+1,329% +$3.3M ﹤0.01% 3635
2020
Q3
$190K Sell
5,374
-1,569
-23% -$55.5K ﹤0.01% 5145
2020
Q2
$169K Sell
6,943
-13,233
-66% -$322K ﹤0.01% 5155
2020
Q1
$314K Buy
20,176
+19,176
+1,918% +$298K ﹤0.01% 4638
2019
Q4
$16K Buy
+1,000
New +$16K ﹤0.01% 6152